Spezifische Immuntherapien zur Behandlung von Krebs im Kindesalter = Specific immune therapies for cancer in childhoodRÖSSIG, C; DILLOO, D; JÜRGENS, H et al.Monatsschrift für Kinderheilkunde. 2003, Vol 151, Num 6, pp 646-653, issn 0026-9298, 8 p.Article

Zinc ions are differentially required for the transcription of ribosomal 5S RNA and tRNA in a HeLa-cell extractWINGENDER, E; DILLOO, D; SEIFART, K. H et al.Nucleic acids research. 1984, Vol 12, Num 23, pp 8971-8985, issn 0305-1048Article

IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoproteinDILLOO, D; HANENBERG, H; LION, T et al.Leukemia. 1995, Vol 9, Num 3, pp 419-424, issn 0887-6924Conference Paper

Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipientsLAWS, H. J; KOBBE, G; DILLOO, D et al.The Journal of hospital infection. 2006, Vol 62, Num 1, pp 80-88, issn 0195-6701, 9 p.Article

Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in childrenSCHNEIDER, D. T; CHO, J; LAWS, H. J et al.Bone marrow transplantation (Basingstoke). 2002, Vol 29, Num 5, pp 383-389, issn 0268-3369Article

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcomaBURDACH, S; JÜRGENS, H; GADNER, H et al.Journal of clinical oncology. 1993, Vol 11, Num 8, pp 1482-1488, issn 0732-183XArticle

Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemiaZIBERT, A; THOMASSEN, A; MÜLLER, L et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 23, pp 1707-1717, issn 0969-7128, 11 p.Article

Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS)BIELACK, S. S; RERIN, J. S; DICKERHOFF, R et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 5, pp 353-359, issn 0268-3369, 7 p.Article

Autoimmune disease induced by dendritic cell immunization against leukemiaROSKROW, M. A; DILLOO, D; SUZUKI, N et al.Leukemia research. 1999, Vol 23, Num 6, pp 549-557, issn 0145-2126Article

Immunstimulation durch Interleukin 2 nach autologer Stammzelltransplantation bei Kindern und Jugendlichen mit soliden Tumoren = IL2 Therapy post autologous stem cell transplantation stimulates the production of tumor cytotoxic cytokins in children and adolescents with solid tumorsLAWS, H. J; DILLOO, D; HANENBERG, H et al.Klinische Pädiatrie. 1993, Vol 205, Num 4, pp 257-263, issn 0300-8630Article

Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantationWEBER, C; SCHAPER, J; TIBUSSEK, D et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 3, pp 253-259, issn 0268-3369, 7 p.Article

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemiaYOSHIMI, A; BADER, P; KREMENS, B et al.Leukemia. 2005, Vol 19, Num 6, pp 971-977, issn 0887-6924, 7 p.Article

Tumor vaccines : application to childhood cancerROSKROW, M. A; ZIBERT, A; SOUQUET, M et al.Klinische Pädiatrie. 1999, Vol 211, Num 4, pp 336-346, issn 0300-8630Conference Paper

Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaMEISSNER, B; BORKHARDT, A; MAECKER, B et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 10, pp 945-949, issn 0268-3369, 5 p.Article

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early interventionCORBACIOGLU, S; GREIL, J; BASU, O et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 2, pp 189-195, issn 0268-3369, 7 p.Article

Immuntherapeutische Behandlung therapierefraktärer und rezidivierter akuter lymphatischer Leukämien im Kindes- und Jugendalter : Onkologische Erkrankungen = Immunotherapy of refractory and relapsed acute lymphoblastic leukemia in childhood and adolescenceKRAMM, C. M; KAMEDA, G; BADER, P et al.Monatsschrift für Kinderheilkunde. 2003, Vol 151, Num 2, pp 154-165, issn 0026-9298, 12 p.Article

A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cellsDILLOO, D; RILL, D; ENTWISTLE, C et al.Blood. 1997, Vol 89, Num 1, pp 119-127, issn 0006-4971Article

Treatment of donor T cell-mediated hematopoietic suppression after haploidentical bone marrow transplantation by T cell modulation in a patient with severe combined immunodeficiencyDILLOO, D; HANENBERG, H; SCHNEIDER, E. M et al.Bone marrow transplantation (Basingstoke). 1992, Vol 9, Num 1, pp 57-62, issn 0268-3369Article

Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptorBURDACH, S; ZASSACK, N; DILLOO, D et al.The Journal of clinical investigation. 1991, Vol 87, Num 6, pp 2114-2121, issn 0021-9738Article

Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenaseMEISEL, R; BROCKERS, S; HENSCHLER, R et al.Leukemia. 2011, Vol 25, Num 4, pp 648-654, issn 0887-6924, 7 p.Article

Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cellsEBELING, Peter; BACH, P; FLASSHOVE, M et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 3, pp 199-209, issn 0171-5216, 11 p.Article

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effectiveBADER, P; KREYENBERG, H; GRUHN, B et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 8, pp 815-821, issn 0268-3369, 7 p.Article

CD40 ligand induces an antileukemia immune response in vivoDILLOO, D; BROWN, M; ROSKROW, M et al.Blood. 1997, Vol 90, Num 5, pp 1927-1933, issn 0006-4971Article

Bone marrow fibroblasts from children with aplastic anemia exhibit reduced interleukin-6 production in response to cytokines and viral challengeDILLOO, D; VÖHRINGER, R; JOSTING, A et al.Pediatric research. 1995, Vol 38, Num 5, pp 716-721, issn 0031-3998Article

Experimentelle Grundlagen einer Therapie-orientierten pathogenetischen Klassifikation der Aplastischen Anämie im Kindesalter = Experimental basis of a therapy-Oriented pathogenic classification of Aplastic Anemia in chilhoodBURDACH, S; VÖHRINGER, R; DILLOO, D et al.Klinische Pädiatrie. 1994, Vol 206, Num 4, pp 201-207, issn 0300-8630Conference Paper